Description
Humana Press Platelet Glycoprotein IIb IIIa Inhibitors in Cardiovascular Disease 2nd Edition 2003 Hardbound by A. Michael Lincoff
1 Thrombosis in Acute Coronary Syndromes and Coronary Interventions.- 2 Platelet Adhesion.- 3 Glycoprotein IIb/IIIa in Platelet Aggregation and Acute Arterial Thrombosis.- 4 Glycoprotein IIb/IIIa Antagonists: Development of Abciximab and Pharmacology of Abciximab, Tirofiban, and Eptifibatide.- 5 Abciximab During Percutaneous Coronary Intervention: EPIC, EPILOG, and EPISTENT Trials.- 6 Eptifibatide in Coronary Intervention: The IMPACT and ESPRIT Trials.- 7 Tirofiban in Interventional Cardiology: The RESTORE and TARGET Trials.- 8 Overview of the Glycoprotein IIb/Illa Interventional Trials.- 9 The Use of Abciximab in Therapy-Resistant Unstable Angina: Clinical and Angiographic Results of the CAPTURE Pilot Trial and the CAPTURE Study.- 10 Unstable Angina Trials: PARAGON, PURSUIT, PRISM, PRISM-PLUS, and GUSTO-IV.- 11 Platelet Glycoprotein IIb/IIIa Inhibitors and an Invasive Strategy.- 12 Glycoprotein IIb/IIIa Receptor Blockade in Myocardial Infarction: Adjunctive Therapy to Percutaneous Coronary Interventions.- 13 Glycoprotein IIb/IIIa Receptor Blockade in Acute Myocardial Infarction: Adjunctive Therapy to Fibrinolysis.- 14 Economics of Glycoprotein IIb/IIIa Inhibition.- 15 Platelet Monitoring and Interaction of Glycoprotein IIb/IIIa Antagonists with Other Antiplatelet Agents.- 16 Platelet Glycoprotein IIb/IIIa Antagonists: Their Interaction with Low-Molecular-Weight Heparins and Direct Thrombin Inhibitors.- 17 Oral Agents.- 18 Platelet Glycoprotein IIb/IIIa Inhibitors: Effects Beyond the Platelet.- 19 Cerebrovascular Interventions.- 20 Cerebrovascular Aspects of Glycoprotein IIb/IIIa Receptor Inhibitors.- 21 Evolution of Drug Development in Evidence-Based Medicine: Summary and the Future.